Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-18 10:25 am Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 4,023,860 19.900% | 148,282 (+3.83%) | Filing History |
| 2024-01-18 10:23 am Unchanged | 2023-12-31 | 13G | P10, Inc. PX | FEDERATED HERMES INC. FHI | 3,181,933 5.990% | 0 (Unchanged) | Filing History |
| 2024-01-18 10:21 am Purchase | 2023-12-31 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,351,275 19.320% | 150,000 (+12.49%) | Filing History |
| 2024-01-18 10:19 am Purchase | 2023-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,637,309 6.300% | 1,498,609 (+70.07%) | Filing History |
| 2024-01-18 10:17 am Purchase | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 10,169,600 17.370% | 4,938,000 (+94.39%) | Filing History |
| 2024-01-18 10:15 am Purchase | 2023-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | FEDERATED HERMES INC. FHI | 3,883,775 6.030% | 1,019,275 (+35.58%) | Filing History |
| 2024-01-18 10:11 am Purchase | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,886,153 15.030% | 252,364 (+2.37%) | Filing History |
| 2024-01-18 10:10 am Sale | 2023-12-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 11,364,666 8.790% | -1,275,697 (-10.09%) | Filing History |
| 2024-01-17 2:43 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,711,512 17.630% | 471,958 (+11.13%) | Filing History |
| 2024-01-17 2:36 pm Sale | 2023-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,272,761 6.830% | -11,456 (-0.35%) | Filing History |
| 2023-12-08 4:16 pm Purchase | 2023-11-30 | 13G | Federated Hermes, Inc. FHI | The Vanguard Group | 8,713,532 10.100% | 229,705 (+2.71%) | Filing History |
| 2023-11-07 12:57 pm Sale | 2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 258,790 4.040% | -316,236 (-55.00%) | Filing History |
| 2023-09-07 10:14 am Sale | 2023-08-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,341,335 4.110% | -3,963,147 (-62.86%) | Filing History |
| 2023-08-08 08:36 am Sale | 2023-07-31 | 13G | Annexon, Inc. ANNX | FEDERATED HERMES INC. FHI | 2,342,715 4.410% | -715,085 (-23.39%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 7,913,438 8.800% | -4,412,580 (-35.80%) | Filing History |
| 2023-06-09 08:35 am Sale | 2023-05-31 | 13G | MALLINCKRODT PLC SHS MNKTQ | FEDERATED HERMES INC. FHI | 515,988 3.920% | -482,970 (-48.35%) | Filing History |
| 2023-06-09 08:19 am Purchase | 2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,633,789 16.660% | 7,409,689 (+229.82%) | Filing History |
| 2023-05-10 10:16 am Sale | 2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 575,026 9.000% | -329,271 (-36.41%) | Filing History |
| 2023-05-10 09:58 am Purchase | 2023-04-30 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 3,875,578 19.900% | 970,752 (+33.42%) | Filing History |
| 2023-04-10 11:50 am Sale | 2023-03-31 | 13G | Xponential Fitness, Inc. XPOF | FEDERATED HERMES INC. FHI | 1,627,737 4.950% | -247,263 (-13.19%) | Filing History |